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SUMMARY.-The hamster cheek pouch is an immunologically privileged site.
The present study is of simple implantation of human tumours direct from
operative specimen to cheek pouch, in particular to determine whether tumour
type influences the rate of successful implant. All implants were studied 10
or 20 days later. The use of cortisone significantly improved the number of
implants growing.
Carcinomas of the cervix were found to show growth in 55% of implants,
in animals conditioned with cortisone. Growth from tumours of the uterine
body, or from colorectal carcinomas, occurred in 25-300,1 of implants. Breast
cancer gave poor results.
THE liamster cheek pouch is immunologically privileged and as such it lias
been used for the growth of human tumours. Previous investigations have
focused on the establishment of permanently heterotransplantable tumours
rather than on the numbers of tumours growing after primary implantation;
this latter problem was the subject ofinvestigation of this paper.
MATERIALS AND METHODS
Golden hamsters were random bred, ofeither sex, 8-12 weeks of age. A short
initial study, using a transplantable hamster sarcoma obtained from the Chester-
Beatty Institute, confirmed the use of simple implantation as preferable to
implantation in cheek pouch chambers, for the purpose of these experiments.
Human tumours were obtained from the operation theatres of the Cardiff
UiiitedHospitals. Pieces oftumour wereplaced indry sterileuniversalcontainers,
and then in a 4' C. refrigerator until collected. In most instances not more thail
1-2 hourselapsed before the tumours wereimplanted into the hamstercheekpoucb. Each tumour was implanted into both pouches of up to 12 animals (i.e.) 24 im-
plants per tumour.
The method ofimplantation used was basically that ofLutz, Fulton, Patt and
Handler (1950). Hamsters were anaesthetized with pentobarbitone sodium;
the cheek pouches were everted and cleaned. Fragments of tumour of around
I MM3 were placed in a sterile I mm. trocar and inserted beneath the epithelium
into the loose areolar connective tissue at the blind end of pouch (Fig. 1). A
piece ofthe original tumour was fixed in Bouin's fluid at the time ofimplantation. One implant was removed after 10 days, and the other at 20 days, under
anaesthesia. Implants and tumour biopsies were processed in the standard -xvav.
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Criteriaofgrowth
An implant was considered to be
"growing
" only when mitotic figures were
present (Fig. 2), ineasilyrecognizable tumour tissue; histologically and in mitotic
index the implant had to be comparable with the original tumour. Implants
were considered as
" surviving
" when there was recognizable tumour tissue; in a
negative implant the tumour was either necrotic orreplaced by bost tissue.
Conditioning of hamster
Half of the animals implanted with each tumour were given subcutaneous
injections of cortisone acetate, 2 mg. at the time ofinjection and thereafter twice
weekly.
RESULTS
A total of 72 human tumours were used in the experiments-including 22
breast tumours, II uterine cancers, and 15 gastro-intestinal adenocarcinomas.
TABLEI.--The Number ofTumour8Giving Growth
" in at least oneImplant
No. of
tumours Growth in one
Tumour type implanted or more implant
Carcinoma
Breast 21 3
Stomach 6 2
Colon 9 4
Cervix uteri 7 6
Uterine body 4 3
Others 6 3
Melanoma 8 4
CNS tumours 11 2
72 27 (37-5%)
In Table I the number of tumours giving growth in at least one implant is
shown. The uterine and gastro-intestinal tumours are seen to give the. best
results. Ofthe 72 tumours, 28 grew in at least one implant (39%).
TABLEII.-Human Tumours. Comparative Results ofImplantation to
Cortisone Treated and Untreated Animals
No. of No.
Treatment implants growing x2 p
Cortisone . 316 123 37.44 <0-001
No treatment 296 49
Twenty-eight tumours are included, each was implanted to an equal number of cortisone
treated and untreated animals
EXPLANATION OF PLATES
FIG. I.-The method of trocar implantation of tumours into the pouch. Fict. 2.-Implant of bladder carcinoma showing
" growth ". Mitotic figures are present.
x 140.
FIG. 3.-Implant of tumour after 20 days in the pouch (a), compared with primary tumour
before ixnplantation (b). Squamous cell carcinoma ofcervixi x 140.
FIG. 4.-Implant ofadenocarcinoma ofstomach after pouch growth for 20 days (a); (b) is the
histology ofthe original specimen. x 140.
FIG. 5.-Craniopharyngioma in a cortisone treated (a), and in an untreated (b), hamster.
Implants removed after 10 days growth. x 140.a)
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In Table II these 28 tumours have been divided to show those implants made
in cortisone treated, and those in untreated, animals. The number ofimplants
growing in cortisone treated animals is seen to be significantly greater than the
number in normal hamsters (P < 0-001).
A series of methylcholanthrene induced rat sarcomas were implanted in a
similar fashion to the humanseries, in apriorstudy to assess the effect ofcortisone
treatment; a similar result to the effect on human tumourimplants was obtained
(Table III).
TABLF, III.-Results ofInbplantation ofSevenlRat Sarcomas. Each was
Implanted to Equal Numbers of Cortisone Treated and Untreated Animals
No. of No.
Treatment implants growing x2 p
Cortisone . 60 32 27-1 <0-001
No treatment 54 5
Table IV shows the results obtained with all the various human tumours, in
cortisoned animalsonly. Theresults areexpressed asthenumberofsuchimplants growing as a percentage of the number implanted, for each tumour. Squamous
carcinomas ofthe uterine cervix gave the bestresult, followedbyadenocarcinomas
of the uterine body, and by adenocareinomas ofthe colon and rectum. Very few
implants of breast carcinomas showedgrowth.
The best results were obtained from certain tumour types, in cortisone con-
ditioned animals (Table IV) : 54-9% of all implants of squamous cell carcinomas
ofthe uterine cervix grew on primaryimplantation and more than one quarter of
implants of carcinomas ofthe uterinebody and ofthe colon, grew likewise.
TABLEIV.-The, Number ofImplants Giving
" Growth
" in Animals Treated
with Cortisone. Analysis by Tumour Site
Tumours Implants
A r- A
I
Type No. No. Growth % Growth
Carcinoma cervix uteri 7 82 45 54-9
Carcinoma body uterus 4 48 14 29-2
Carcinoma colon 9 106 28 26- 5
Carcinoma stomach 6 72 8 11.1
Melanoma 8 91 9 10.0
Carcinoma breast 21 272 7 2-2
Fig. 3 and 4 show growing implants of a carcinoma of the cervix and a car-
cinoma ofthe stomach, each compared with the histolo v oftheoriginal specimen 9"
at operation.
DISCUSSION
The hamster cheek pouch is immunologically privileged with regard to the
reception ofxenografts (Billingham and Silvers, 1964). The site has been usedby previous workers for thetransplantation ofhuman tumours (Chute, Sommers and
Warren, 1952; Handler, Davis andLSomers, 1956; Toolan, 1953). There bave been
few systematic attempts to discover which tumour types grow best on such
implantation; many of the papers have focused on the establishment of a few
tumours in permanent passage, rather than on the number ofimplants that will536 1). E. WILLIAMS, D. M. D. EVANS AND R. W. BLAMEY
grow on placement direct from the primary tumour. In addition the criteria
for accepting an implant as positive vary from series to series and the times of
growth before examination oftheiniplant have varied, and at times have not been
stated.
The present series was designed to establish which tumour types are likely to
grow on transplantation to the cheek pouch. The times for examination of
implants as 10 or 20 days were chosen, because these periods aive time for estab-
lishment of the tumour, and ifrequired time to assay the effect ofantineoplastic
drugs. The criteria for accepting an implant as showing
" growth
"' were strict.
Many other implants preserved an easily recognizable cell structure, but did iiot
have mitoses. Again, if the method is to be used to stiidy tumour growth. or
antimitotic drug sensitivity, then mitoses must be present in successful im-
plants.
Cortisone treatment of recipient animals has been accepted as increasing the
number ofimplants growing (Handler et al., 1956; Toolan, 1953) but this has inot
beeii shown in direct comparison with unconditioned animals; both the present
series of human tumours and ttie series of rat tumours confirm the benefit of
cortisone administration in this respect. The effect of attempted tolerance
induction to rat titmours was also investigated, in a similar series to that assessing
the effect ofcortisone, but this gave no greater incidence ofpositive implants.
The niode ofaction ofcortisone inincreasing the nuniber ofsuccessftilimplants
is a matter of dispute: Crabb and Kelsall (1951) attribute it to diminution of
lympboid tissue; Cohen (1961) to a slowing oflymphocytic infiltration of hetero-
grafts; Smith (1967) to slower vascularization of the implants. Histologically
implants in cortisone treated animals were found to provoke little or no host
response; implants in untreated animals were surrounded by a dense layer of
inflammatory cells (Fig. 5).
Wliy certain tumours grew in the pouch and others not, is unexplained.
Uterine tuniours did well as a group. Squamous cell carcinomas of the cervix
grew best, and this accords with the report (Handler, Davis, Somers, 1956) that
epidermal carcinomas grow well on implantation. Gastro-intestinal tumours gave
a fair result, breast carcinomas a very poor result. This latterfinding may be re-
lated to the bormonal environment; arough attempt to correct this, by adminis-
tering oestradiol to the bamsters implanted witb. five breast tumours was lin-
successful.
The series of human tumours demonstrates that certain tumour types grow
well on heterotransplantation to the hamster cheek poueb, using only cortisone
suppression of the immune response of the recipient. Witb- 25-50% of animals
implanted with these tumours, giving a growing implant (remember each animal
has two pouches), the method seems viable for the study of the effect of antineo-
plastic agents. The system preserves the whole architecture of the tumours, in
contradistinction to tissue culture; itprovidesample time for the action of adrug,
and gives a comparison of the effect of the drug on host vital systems as well as
on tumours.
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